1,236 results on '"Fiorentino, Michelangelo"'
Search Results
52. An Apparent Diffusion Coefficient-Based Machine Learning Model Can Improve Prostate Cancer Detection in the Grey Area of the Prostate Imaging Reporting and Data System Category 3: A Single-Centre Experience
53. Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer
54. Supplementary Figure from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
55. Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
56. Abstract 737: Variation in prognostic value of Gleason score for lethal prostate cancer using time-varying area under the curve
57. Supplementary Data from AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
58. Data from Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions
59. Supplementary Figure 1 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
60. Supplementary Figure 4 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
61. Supplementary Tables 1-12, Supplementary Figures 1-2 from The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer
62. Supplementary Figure 2 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
63. Supplementary Table and Figure Legends from The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer
64. Supplementary Figure 3 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
65. Data from The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer
66. Supplementary Tables 1-5, Supplementary Figures 1-3 from Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions
67. Supplementary Data from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
68. Data from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
69. Supplementary Table 1 from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum
70. Molecular Imaging and Precision Medicine in Prostate Cancer
71. PD-L1 Expression is Associated With Poor Prognosis in Renal Cell Carcinoma
72. The Tumor Entity Denominated “clear cell-papillary renal cell carcinoma” According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome
73. Correlation between MGMT promoter methylation and response to temozolomide-based therapy in neuroendocrine neoplasms: an observational retrospective multicenter study
74. Supplementary Figure 3 from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
75. Supplementary Table 4 from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer
76. Supplementary Figure 1 from The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
77. Supplementary Figure 2 from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
78. Supplementary Table 3 from The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
79. Supplementary Table 3 from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer
80. Data from Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer
81. Supplementary Table 1 from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer
82. Data from The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
83. Supplementary Data from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
84. Supplementary Figure 1 from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer
85. Supplementary Table 2 from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer
86. Supplementary Tables 1, 2, 4 and 5 from The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
87. Data from Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer
88. Supplementary Table S1 from Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer
89. Supplementary figure legend from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
90. Supplementary Figure 4 from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
91. Supplementary Figure 1 from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
92. The new classification of renal cell carcinoma: what is the clinical issue?
93. Transverse prostate maximum sectional area can predict clinically significant prostate cancer in PI-RADS 3 lesions at multiparametric magnetic resonance imaging
94. Yolk sac tumor of postpubertal-type does not exhibit immunohistochemical loss of SMARCB1/INI1 and SMARCA4/BRG1…but choriocarcinoma?
95. Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn’s disease
96. Role of Inter-Observer Variability and Quantification of Muscularis Propria in the Pathological Staging of Bladder Cancer
97. Vascular morphology differentiates prostate cancer mortality risk among men with higher Gleason grade
98. A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor
99. FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal‐type.
100. Quantity and quality of nucleic acids extracted from archival formalin fixed paraffin embedded prostate biopsies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.